News & Updates

In individuals with advanced solid malignancies, subcutaneous (SC) amivantamab administered once a month is associated with fewer infusion-related reactions (IRRs) and offers more convenience than the IV formulation, the phase Ib PALOMA study suggest.

A team of researchers has developed a new platform to screen for lung cancer, with the approach involving inhaling tiny sensors, collecting a urine sample, and then analysing it using a paper strip.

New drug applications approved by US FDA as of 1-15 April 2024 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Blood pressure (BP) slightly decreases in patients with obstructive sleep apnoea who undergo continuous positive airway pressure (CPAP) therapy, as seen in a study. Such effect is marginally higher in those with above-average apnea-hypopnea index (AHI).